WeChat Mini Program

Old Version Features

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

A Phase 1 Study of PIT565, a First-in-Class, Anti-CD3, Anti-CD19, Anti-CD2 Trispecific Antibody in Patients with Relapsed And/or Refractory B-Cell Malignancies

Irit Avivi Mazza,Pere Barba,Junichiro Yuda,Maria Lia Palomba,Juan Pablo Alderuccio,Ciel de Vriendt,Paolo Corradini,Francesca Lorraine Wei Inng Lim,Pier Luigi Zinzani,Nitin Jain,Jessica T. Leonard,Michelle Coulson,Nadia Hassounah, Xiaoling Yang,Haihui Lu,Andrew Lewandowski,Joseph Ryan Polli, Matthieu Klopfenstein,Alessandro Pastore,Gabriel Brisou

BLOOD（2023）

Cited 1|Views10

Key words

T Cell Therapy

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined